aminolevulinic acid has been researched along with Papilloma in 11 studies
Aminolevulinic Acid: A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS.
5-aminolevulinic acid : The simplest delta-amino acid in which the hydrogens at the gamma position are replaced by an oxo group. It is metabolised to protoporphyrin IX, a photoactive compound which accumulates in the skin. Used (in the form of the hydrochloride salt)in combination with blue light illumination for the treatment of minimally to moderately thick actinic keratosis of the face or scalp.
Papilloma: A circumscribed benign epithelial tumor projecting from the surrounding surface; more precisely, a benign epithelial neoplasm consisting of villous or arborescent outgrowths of fibrovascular stroma covered by neoplastic cells. (Stedman, 25th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "To explore the therapeutic effect of topical 5-Aminolevulinic Acid photodynamic therapy (ALA-PDT) on laryngeal papillomatosis (LP) treatment." | 7.91 | Topical 5-aminolevulinic acid photodynamic therapy for laryngeal papillomatosistosis treatment. ( Cai, Q; Chen, R; Han, P; Huang, X; Liang, F; Lin, P; Luo, M, 2019) |
| " In this study, we used 5-aminolevulinic (ALA) acid and 3 water soluble photosensitizers-PP(Arg)(2), PP(Ser)(2)Arg(2), PP(Ala)(2)Arg(2), all diamino acid derivatives of protoporphyrin IX-to treat benign papillomas in FVB/N mice induced by 7,12-dimethylbenz(a)anthracene (DMBA)-12-O-tetradecanoyl-phorbol-13-acetate (TPA)." | 7.75 | Photodynamic therapy with 5-aminolevulinic acid and diamino acid derivatives of protoporphyrin IX reduces papillomas in mice without eliminating transformation into squamous cell carcinoma of the skin. ( Dziadziuszko, H; Glosnicka, R; Graczyk, A; Jankowski, D; Jaskiewicz, K; Juzeniene, A; Kaliszewski, M; Kunikowska, D; Kwasny, M; Kwitniewski, M; Ma, LW; Moan, J; Peksa, R, 2009) |
| "The detection rate of HPV infections was 76." | 5.51 | Topical 5-aminolevulinic acid photodynamic therapy for laryngeal papillomatosistosis treatment. ( Cai, Q; Chen, R; Han, P; Huang, X; Liang, F; Lin, P; Luo, M, 2019) |
| "To explore the therapeutic effect of topical 5-Aminolevulinic Acid photodynamic therapy (ALA-PDT) on laryngeal papillomatosis (LP) treatment." | 3.91 | Topical 5-aminolevulinic acid photodynamic therapy for laryngeal papillomatosistosis treatment. ( Cai, Q; Chen, R; Han, P; Huang, X; Liang, F; Lin, P; Luo, M, 2019) |
| " The purpose of this study was to evaluate the treatment outcome and safety of PDT with aminolevulinic acid (5-ALA) combined with surgical curettage for lip florid papillomatosis." | 3.83 | Treatment of lip florid papillomatosis with topical ALA-PDT combined with curettage: Outcome and safety. ( Gao, Y; Liu, J; Lu, YG; Wang, HL; Wang, WS, 2016) |
| "In this study, 4 cases of lip florid papillomatosis were treated with topical aminolevulinic acid photodynamic therapy (ALA-PDT) combined with curettage." | 3.83 | Treatment of lip florid papillomatosis with topical ALA-PDT combined with curettage: Outcome and safety. ( Gao, Y; Liu, J; Lu, YG; Wang, HL; Wang, WS, 2016) |
| " In this study, we used 5-aminolevulinic (ALA) acid and 3 water soluble photosensitizers-PP(Arg)(2), PP(Ser)(2)Arg(2), PP(Ala)(2)Arg(2), all diamino acid derivatives of protoporphyrin IX-to treat benign papillomas in FVB/N mice induced by 7,12-dimethylbenz(a)anthracene (DMBA)-12-O-tetradecanoyl-phorbol-13-acetate (TPA)." | 3.75 | Photodynamic therapy with 5-aminolevulinic acid and diamino acid derivatives of protoporphyrin IX reduces papillomas in mice without eliminating transformation into squamous cell carcinoma of the skin. ( Dziadziuszko, H; Glosnicka, R; Graczyk, A; Jankowski, D; Jaskiewicz, K; Juzeniene, A; Kaliszewski, M; Kunikowska, D; Kwasny, M; Kwitniewski, M; Ma, LW; Moan, J; Peksa, R, 2009) |
| "Endogenously induced protoporphyrin IX (PPIX), a metabolite of delta-aminolaevulinic acid (ALA), has been evaluated as a photosensitising agent for destruction of papillomas in cottontail rabbit papillomavirus-infected Dutch belted and New Zealand rabbits." | 3.69 | Efficacy of intravenous delta-aminolaevulinic acid photodynamic therapy on rabbit papillomas. ( Lee, CJ; Lofgren, LA; Nouri, M; Ronn, AM; Steinberg, BM; Yoo, D, 1995) |
| "The detection rate of HPV infections was 76." | 1.51 | Topical 5-aminolevulinic acid photodynamic therapy for laryngeal papillomatosistosis treatment. ( Cai, Q; Chen, R; Han, P; Huang, X; Liang, F; Lin, P; Luo, M, 2019) |
| "The combined treatment of topical ALA-PDT and curettage was proven to be safe and effective in lip florid papillomatosis." | 1.43 | Treatment of lip florid papillomatosis with topical ALA-PDT combined with curettage: Outcome and safety. ( Gao, Y; Liu, J; Lu, YG; Wang, HL; Wang, WS, 2016) |
| " The purpose of this study was to evaluate the treatment outcome and safety of PDT with aminolevulinic acid (5-ALA) combined with surgical curettage for lip florid papillomatosis." | 1.43 | Treatment of lip florid papillomatosis with topical ALA-PDT combined with curettage: Outcome and safety. ( Gao, Y; Liu, J; Lu, YG; Wang, HL; Wang, WS, 2016) |
| "In this study, 4 cases of lip florid papillomatosis were treated with topical aminolevulinic acid photodynamic therapy (ALA-PDT) combined with curettage." | 1.43 | Treatment of lip florid papillomatosis with topical ALA-PDT combined with curettage: Outcome and safety. ( Gao, Y; Liu, J; Lu, YG; Wang, HL; Wang, WS, 2016) |
| "There was no other recurrence at 6 months off treatment." | 1.43 | Treatment of lip florid papillomatosis with topical ALA-PDT combined with curettage: Outcome and safety. ( Gao, Y; Liu, J; Lu, YG; Wang, HL; Wang, WS, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Liang, F | 1 |
| Han, P | 1 |
| Chen, R | 1 |
| Lin, P | 1 |
| Luo, M | 1 |
| Cai, Q | 1 |
| Huang, X | 1 |
| Zhou, X | 1 |
| Zheng, M | 1 |
| Zou, Y | 1 |
| Wang, J | 1 |
| Zhang, L | 1 |
| Yin, R | 1 |
| Takahashi, H | 2 |
| Nakajima, S | 2 |
| Ogasawara, K | 1 |
| Asano, R | 2 |
| Nakae, Y | 2 |
| Sakata, I | 2 |
| Iizuka, H | 2 |
| Sun, IS | 1 |
| Kirollos, R | 1 |
| Santarius, T | 1 |
| Gao, Y | 1 |
| Wang, HL | 1 |
| Wang, WS | 1 |
| Liu, J | 1 |
| Lu, YG | 1 |
| Kwitniewski, M | 1 |
| Jankowski, D | 1 |
| Jaskiewicz, K | 1 |
| Dziadziuszko, H | 1 |
| Juzeniene, A | 1 |
| Moan, J | 1 |
| Ma, LW | 1 |
| Peksa, R | 1 |
| Kunikowska, D | 1 |
| Graczyk, A | 1 |
| Kwasny, M | 1 |
| Kaliszewski, M | 1 |
| Glosnicka, R | 1 |
| Togsverd-Bo, K | 1 |
| Haedersdal, M | 1 |
| Wulf, HC | 1 |
| Lofgren, LA | 1 |
| Ronn, AM | 1 |
| Nouri, M | 1 |
| Lee, CJ | 1 |
| Yoo, D | 1 |
| Steinberg, BM | 1 |
| Leunig, A | 1 |
| Betz, CS | 1 |
| Mehlmann, M | 1 |
| Stepp, H | 1 |
| Arbogast, S | 1 |
| Grevers, G | 1 |
| Baumgartner, R | 1 |
| Casas, A | 1 |
| Perotti, C | 1 |
| Fukuda, H | 1 |
| Rogers, L | 1 |
| Butler, AR | 1 |
| Batlle, A | 1 |
11 other studies available for aminolevulinic acid and Papilloma
| Article | Year |
|---|---|
Topical 5-aminolevulinic acid photodynamic therapy for laryngeal papillomatosistosis treatment.
Topics: Administration, Topical; Adult; Aminolevulinic Acid; Child; Child, Preschool; Female; Humans; Infant | 2019 |
5-Aminolevulinic acid induced photodynamic therapy (ALA-PDT) for erosive adenomatosis of the nipple: A case report.
Topics: Adenoma; Adult; Aminolevulinic Acid; Breast Neoplasms; Female; Humans; Nipples; Papilloma; Photochem | 2021 |
Photodynamic therapy using a novel irradiation source, LED lamp, is similarly effective to photodynamic therapy using diode laser or metal-halide lamp on DMBA- and TPA-induced mouse skin papillomas.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Aminolevulinic Acid; Animals; Female; Lasers, Semiconductor; Mice; | 2014 |
No 5-ALA fluorescence seen in a recurrent papillary tumour of the pineal region (PTPR).
Topics: Adult; Aminolevulinic Acid; Brain Neoplasms; Female; Fluorescence; Humans; Neoplasm Recurrence, Loca | 2015 |
Treatment of lip florid papillomatosis with topical ALA-PDT combined with curettage: Outcome and safety.
Topics: Administration, Topical; Adult; Aminolevulinic Acid; Combined Modality Therapy; Curettage; Dose-Resp | 2016 |
Photodynamic therapy with 5-aminolevulinic acid and diamino acid derivatives of protoporphyrin IX reduces papillomas in mice without eliminating transformation into squamous cell carcinoma of the skin.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Aminolevulinic Acid; Animals; Carcinogens; Carcinoma, Squamous Cel | 2009 |
Photodynamic therapy for tumors on the eyelid margins.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Basal Cell; Eyelid Neoplasms; Humans; Middl | 2009 |
Photodynamic therapy using a novel photosensitizer, TONS501, is similarly effective to ALA and EC036 photodynamic therapy on DMBA-and TPA-induced mouse skin papilloma.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Administration, Topical; Aminolevulinic Acid; Animals; Disease Mod | 2012 |
Efficacy of intravenous delta-aminolaevulinic acid photodynamic therapy on rabbit papillomas.
Topics: Aminolevulinic Acid; Animals; Papilloma; Photochemotherapy; Protoporphyrins; Rabbits; Skin | 1995 |
A pilot series demonstrating fluorescence staining of laryngeal papilloma using 5-aminolevulinic acid.
Topics: Administration, Topical; Adult; Aminolevulinic Acid; Female; Fluorescent Dyes; Humans; Laryngeal Neo | 2000 |
ALA and ALA hexyl ester-induced porphyrin synthesis in chemically induced skin tumours: the role of different vehicles on improving photosensitization.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Aminolevulinic Acid; Animals; Female; Kidney; Liver; Mice; Neoplas | 2001 |